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A B S T R A C T
Objective: A systematic review of the literature to determine whether in patients with neurological
heterotopic ossiﬁcation (NHO) after traumatic brain injury, the extent of the neurological sequelae, the
timing of surgery and the extent of the initial NHO affect the risk of NHO recurrence.
Data sources: We searched MEDLINE via PubMed and Cochrane library for articles published up to June
2015. Results were compared with epidemiological studies using data from the BANKHO database of
357 patients with central nervous system (CNS) lesions who underwent 539 interventions for
troublesome HO.
Results: A large number of studies were published in the 1980s and 1990s, most showing poor quality
despite being performed by experienced surgical teams. Accordingly, results were contradictory and
practices heterogeneous. Results with the BANKHO data showed troublesome NHO recurrence not
associated with aetiology, sex, age at time of CNS lesion, multisite HO, or ‘‘early’’ surgery (before
6 months). Equally, recurrence was not associated with neurological sequelae or disease extent around
the joint.
Conclusions: The recurrence of NHO is not affected by delayed surgery, neurological sequelae or disease
extent around the joint. Surgical excision of NHO should be performed as soon as comorbid factors are
under control and the NHO is sufﬁciently constituted for excision.
 2016 Elsevier Masson SAS. All rights reserved.
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Although patients with traumatic brain injury (TBI) mainly
show medium and long-term cognitive and behavioral disorders
[1,2], motor and orthopedic sequelae may be involved in the
difﬁculties they face. Neurogenic heterotopic ossiﬁcation (NHO)
occurs in 4% to 23% of patients after TBI [3–8], and for
approximately 45% of patients with NHO, the disease occurs in
2 or more locations [5,9–11]. The disease involves the growth of
bony tissue around joints. This growth can be painful and may
also have functional consequences because it can limit joint* Corresponding author at: Service de me´decine physique et de re´adaptation,
hoˆpital Raymond-Poincare´, 104, boulevard Raymond-Poincare´, 92380 Garches,
France. Tel.: +33 1 47 10 70 70; fax: +33 1 47 10 70 73.
E-mail address: francois.genet@rpc.aphp.fr (F. Geneˆt).
http://dx.doi.org/10.1016/j.rehab.2016.03.009
1877-0657/ 2016 Elsevier Masson SAS. All rights reserved.range of motion. The timing of NHO occurrence after TBI varies
greatly, from 2 to 3 months or more. This discrepancy in
occurrence is mainly due to difﬁculties in diagnosing the
condition [8]. The mechanisms causing NHO are still poorly
understood.
Attempts have been made to develop prophylactic treatments
for NHO. Studies of patients with spinal cord injury (SCI) provide
strong support for the use of non-steroidal anti-inﬂammatory
drugs (NSAIDs) [12]; however, their use is limited by their side
effects [13–15]. Currently, the only treatment for NHO is surgical
excision, and management of the condition lacks guidelines
[13,16]. Surgical excision is effective [10,17,18] for increasing
range of motion [19–25] and importantly, improving both active
and passive (e.g., access to the perineum or axilla for hygiene)
function [19,20,26], reducing pain (i.e., nerve decompression)
[20,26,27] and ameliorating bedsores [20].
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show recurrence of symptomatic NHO, with renewed pain and
loss of range of motion and function. Empirical beliefs regarding
the causes of recurrence have led to the development of
certain clinical practices for treating NHO [28,29]. For example,
many surgeons prefer to wait until the NHO is mature before
excision [8] even though prolonging surgery may lead to a
cascade of negative events: risk of ankylosis, intra-articular
lesions, bone loss in the femoral head and increased risk of
fracture during or after surgery [30,31]. The severity of the
neurological injury and the extent of the initial NHO is thought
to affect recurrence [8].
Our centre follows many patients with NHO and we have
developed a database, ‘‘BANKHO,’’ containing data for patients who
have undergone surgery for troublesome NHO after CNS lesions
[10]. This database was started in 1993 and was used for a
2009 epidemiological study addressing 3 issues in patients with
different types of CNS lesions [10]: the extent of the neurological
sequelae, timing of surgery and extent of the initial NHO associated
with the risk of NHO recurrence. At that time, the database
contained data for 357 patients, including 539 ﬁrst-time inter-
ventions for NHO (129 for multiple sites). All the surgical
interventions in the database were performed by the same
surgeon (PD). The results showed that most HO requiring surgery
occurred after TBI (199 patients [55.7%]; 304 surgeries [56.4%]).
The hip was the primary site of HO (163/304 [53.6%]), followed by
the elbow (85/304 [28.0%]), knee (43/304 [14.1%]) and shoulder
(13/304 [4.3%]); 16 cases (5.6% [16/304]; 16 patients) showed
recurrence requiring further surgery.
We aimed to use the BANKHO database and literature data to
investigate the validity of the beliefs relating to the post-excision
risk of recurrence of NHO. Three questions were posed: Is there a
relationship between the:
 timing of the excision;
 severity of the neurological sequelae;
 and extent of the initial NHO and risk of recurrence?
2. Materials and methods
2.1. Systematic literature search
We performed a systematic review of the literature following
the PRISMA recommendations (www.prisma-statement.org),
searching for articles published up to June 2015 in English or
French with an available abstract in MEDLINE via PubMed and
Cochrane Library databases with the MeSH headings ‘‘head injury’’,Fig. 1. Selection of articles. Q1: Is there a relationship between the timing of excision and
neurological sequelae and risk of recurrence? (Yes/No); Q3: Is there a relationship b
recurrence? (Yes/No).‘‘traumatic head injury’’, ‘‘heterotopic ossiﬁcation’’ and ‘‘surgery.’’
The titles and abstracts of the studies retrieved were screened to
select those reporting on the timing of HO excision and recurrence
in patients with TBI (excluding spinal cord injury, stroke,
orthopaedic conditions, total hip arthroplasty and burns). The full
texts of the selected studies were independently screened by
2 authors (F.G. and A.S.) for eligibility. From data yielded by the
literature and advice from all authors, the level of evidence of the
proposed recommendations was graded according to the health
authority in France [32] (Table 2).
Studies were classiﬁed as published before 2002 or 2002 and
later. Studies published in 2002 and later were considered to
evaluate current practices, avoiding the confounding factor of
changes in clinical practice. Moreover, during the beginning of
the 2000s, articles providing other points of view concerning the
3 questions were published. Studies before 2002 were consid-
ered to evaluate previous practices. Any reviews discussing
surgery for NHO, timing of surgery and recurrence risk were
selected to investigate changes in clinical practice and recom-
mendations.
2.2. Inclusion and exclusion criteria
Studies had to include patients with TBI who underwent
surgery for troublesome HO. They had to state the aetiology of the
neurological lesion, time from diagnosis to surgery, any post-
surgical complications and any recurrence of HO, with the timing
of the recurrence. Patients had to be followed up for at least
3 months. To answer question 2 (effect of the severity of the
neurological sequelae on recurrence risk), studies also had to
report the functional and/or cognitive status of patients before
surgery. To answer question 3 (effect of the extent of the NHO on
recurrence risk), studies also had to report the results of imaging
(X-ray and/or CT scan) and the clinical assessment.
3. Results
We identiﬁed 208 reports of studies; 67 were included. Overall,
19 articles were published between January 2002 and June 2015
(Fig. 1 and Table 1 [studies only]): 17 on the relationship between
the timing of excision and risk of recurrence (8 reviews
[4,6,7,13,18,20,28,33] and 10 studies [10,21,27,29,34–38]); 7 on
the relationship between the severity of the neurological sequelae
and risk of recurrence (2 reviews [8,33] and 5 studies
[10,27,29,35,38]); and 7 on the relationship between the extent
of the initial NHO and risk of recurrence (3 reviews [8,18,39] and
4 studies [10,27,36,37]). risk of recurrence? (Yes/No); Q2: Is there a relationship between the severity of the
etween the extent of the initial neurological heterotopic ossiﬁcation and risk of
Table 1
Studies published between January 2002 and June 2015.
Author Year No. of
patients
No. of
NHOs
Location
(joint)
Design Mean follow-up
(range) (months)
Rate of
recurrence
Additional
procedure
Q1 Q2 Q3 Level of
evidencea
De Palma 2002 10 14 Elbow Retrospective 23 (12–34) 0/14 Yes Yes N/A C
Melamed 2002 9 12 Hip, knee,
elbow
Prospective 18 (9–50) 0/12 No No N/A C
Fuller 2005 17 22 Knee Retrospective 32 (10–98) 0/17 Etidronate (all)
Radiation (2)
No N/A N/A C
Sorriaux 2005 44 51 Elbow Retrospective 45 (6–48) 2/51 No No N/A C
Carlier 2005 29 45 Hip Prospective 45.5 (8–24) 2/45 No N/A N/A C
Genet 2011 357 539 Hip, knee,
shoulder,
elbow
Cohort study
(both prospective
and retrospective)
6.9 (5.7–19.4) 31/539 NSAID (All)
Radiation (rare)
No N/A N/A B
Genet 2011 95 95 Hip Retrospective
(case–control study)
10.3 (0.7–159.4) 19 NSAID (All)
Radiation (rare)
N/A N/A No C
Mavrogenis 2012 24 33 Hip Retrospective 30 (12–96) 7/33 NSAID (All)
Radiation (All)
N/A N/A No C
Genet 2012 80 80 Hip, elbow Retrospective
(case–control study)
15.5 (2.7–78.5) 16 NSAID (All)
Radiation (rare)
No No N/A C
NHO: neurogenic heterotopic ossiﬁcation; N/A: not addressed; NSAID: non-steroidal anti-inﬂammatory drug. Q1: Is there a relationship between the timing of excision and
risk of recurrence? (Yes/No); Q2: Is there a relationship between the severity of the neurological sequelae and risk of recurrence? (Yes/No); Q3: Is there a relationship between
the extent of the initial NHO and risk of recurrence? (Yes/No).
a Haute Autorite´ de sante´ [32].
W. Almangour et al. / Annals of Physical and Rehabilitation Medicine 59 (2016) 263–269 2653.1. Level of evidence of included studies
The level of evidence of studies was generally poor [32] (Tables
1 and 2). All studies were graded C except one that was graded B
because it was a cohort study with a large number of surgeries
[10]. Most of the other studies were retrospective. Two studies
were prospective, with a lower level of evidence (no randomiza-
tion, non-comparative). There were no randomized control trials
and scales used were frequently not validated for this purpose
mainly because the diagnosis of NHO is always delayed relative to
its occurrence, the incidence is relatively low, sample sizes are
small, and pathogenesis is still poorly understood, so early
diagnosis is difﬁcult. For this reason, we decided to keep all the
studies selected by our process [19].
3.2. Report of the literature
3.2.1. Relationship between the timing of excision and risk of
recurrence
3.2.1.1. Historical background. During the 1990s, following the
experience and publications of Garland et al., several teams agreed
to wait for at least the arbitrary 18 months after TBI beforeTable 2
Level of evidence and grading of recommendations for good practice following the
Haute Autorite´ de sante´ in France.
Grade
A Validated scientiﬁc evidence: based on studies with a high level of
evidence: randomized controlled vs. placebo clinical trials with high
statistical power and without major bias or meta-analysis of
randomized comparative clinical trials, decision analysis based on
well-conducted studies
B Scientiﬁc presumption: based on scientiﬁc presumption using studies
with intermediate level of evidence, such as randomized comparative
trials with low statistical power, well-conducted non-randomized
comparative trials, cohort studies
C Low level of scientiﬁc evidence: based on studies with a lower level of
evidence, such as case studies, retrospective studies, series of cases,
comparative studies with major biases
AE Scientiﬁc expert agreement: in the absence of studies,
recommendations have been based on experts’ opinions resulting
from a workgroup, after having consulted a reading group. The
absence of level of evidence grade does not mean that the
recommendations are not relevant and useful. It must, however,
encourage teams to conduct further studiesconsidering surgery [31,40], mainly to ensure that maximal
neurological recovery had occurred if the aim of surgery was to
improve function, as well as to avoid recurrence (by ensuring NHO
maturity). This delay could be shortened in cases of rapid
neurological recovery [40].
3.2.1.2. Since 2002. It is currently widely accepted that to reduce
the risk of recurrence, the NHO must reach maturity before surgery
[13,20,21,37,38]. However, some studies suggest that this is not
the case [18,22,27,28] and that surgery can be carried out before
12 months to reduce postoperative stiffness [22]. A major problem
is the difﬁculty in determining when the NHO reaches maturity
[6,20,38]. Several methods have been tested (radiography, CT scan,
biological investigations, three-phase bone scan, etc. [20,38]) with
controversial results and samples that were often heterogeneous
after SCI and TBI [38,41]. Moreover, these studies frequently lacked
statistical analysis. In 2007, Chalidis et al. performed a meta-
analysis of 16 studies (255 patients) [28] and could not establish a
relationship between timing of surgery and recurrence of NHO
because of methodological limitations in the studies, including
variability between surgical procedures and surgeon experience,
non-standardized post-surgical management, variability of patient
data ﬁles, lack of consistency within the datasets themselves, and
huge differences in the timing of surgery ranging from 13 to
30 months after TBI. The rate of recurrence was estimated at about
19.8% (95% conﬁdence interval 14.4–26.1%), but the outcome
measures used (new decrease in range of motion, ankylosis,
radiographic recurrence, etc.) were disparate. Shehab et al.
discussed the surgeon’s predicament: waiting for NHO maturity
to avoid recurrence exposes the patient to prolonged pain and loss
of joint motion, which both may reduce functional ability and
probably neurological recovery as well as increase the risk of
postoperative complications such as hematoma or fracture
[4]. Unfortunately, most studies reported disparate rates of NHO
recurrence (from 0 to 92% radiographic recurrence) whatever the
timing of surgery (less or more than 18 months after the CNS
lesion) [21,27,34,35]. One point from these studies is that even if
the timing of surgery and follow-up are heterogeneous, radio-
graphic recurrence (without symptoms) is largely more frequent
than clinical recurrence (with symptoms) and whether the timing
of surgery has an impact on clinical recurrence is not clear. Some
studies did not report enough information regarding the timing of
surgery or the rate of recurrence [38].
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following the surgical interventions performed during the ﬁrst
year after CNS damage. After 1 year, when recurrence occurred, it
was not associated with aetiology, sex, age at time of CNS lesion,
multisite NHO, or ‘‘early’’ surgery (before 6 months) [29,36].
3.2.2. Relationship between severity of the neurological sequelae and
risk of recurrence
3.2.2.1. Historical background. The second factor suspected to
increase the risk of recurrence was the severity of the neurological
sequelae. In the 1980s and 1990s, it was considered that the more
severe the residual deﬁcit (cognitive and motor), the worse the
functional outcome of surgery and the greater the risk of
recurrence [40,42–44]. In 1985, one surgical team experienced
in NHO proposed a subjective clinical scale to evaluate residual
cognitive and functional deﬁcits relating to the brain injury
(Garland status or Rancho Los Amigos status: Class I–minimum
cognitive deﬁcits with minimum physical disability, Class II–
minimum cognitive deﬁcits with moderate physical deﬁcits, Class
III–minimum cognitive deﬁcits with severe physical deﬁcits, Class
IV–moderate to severe cognitive deﬁcits with minimum to
moderate physical disability, and Class V–moderate to severe
cognitive deﬁcits with severe physical disability), speciﬁcally for
decision making in NHO management [42]. The scale is still widely
used for decisions relating to the appropriateness of surgical
excision of NHO and notably to predict the functional results of the
surgery as well as the risk of recurrence [26,43,45].
3.2.2.2. Since 2002. Only a few studies have evaluated the
association between functional/cognitive status or relative gain
in range of motion and recurrence [8,20,38]. They found, using the
Garland status, better motor recovery and improvements in
range of motion for patients with few neurological sequelae.
Some studies did not ﬁnd a greater risk of recurrence, but the
samples were small [38]. Conversely, signiﬁcant functional
improvements after surgery have been reported, even in patients
with severe impairment [27]. The authors of this latter study
suggested that NHO excision should be envisaged as soon as
possible to optimize recovery and quality of life.
3.2.2.3. BANKHO database [10]. A retrospective case–control study
[29] included patients with troublesome HO requiring surgery
after TBI with (case, n = 16) or without recurrence (control, n = 64).
Each patient with HO recurrence was matched with 4 patients
without recurrence after 6 months of follow-up (control patients)
by sex, pathology (TBI), surgical indications for HO and age at the
time of surgery ( 4 years). The authors found no signiﬁcant
relationship between recurrence and timing of surgery, even after
including all matching factors and Garland status in the regression
model. No association was found between the severity of the
neurological sequelae (Garland status) and risk of NHO recurrence
after TBI.
3.2.3. Relationship between the extent of the initial NHO and risk of
recurrence
3.2.3.1. Historical background. The last factor believed to have an
impact on the recurrence of troublesome NHO after CNS lesion is
the extent and the number of NHOs. The most commonly used
classiﬁcation is by Brooker, who developed a method in 1973 to
classify the degree of ectopic bone formation around the hip after
total hip arthroplasty [46]. This classiﬁcation is useful in that it can
be based on a single anteroposterior X-ray of the hip (Class I–island
of bone within the soft tissues about the hip, Class II–bone spurs
from the pelvis or proximal end of the femur leaving at least 1 cm
between opposing bone surfaces, Class III–bone spurs from the
pelvis or proximal end of the femur, reducing the space betweenopposing bone surfaces to < 1 cm, Class IV–apparent bone
ankylosis of the hip). This rating was correlated with global hip
function [47]. With SCI with this classiﬁcation, the extent of the
initial NHO was suggested to be able to predict postoperative
recurrence [48]. Consequently, experienced teams considered that
Brooker’s classiﬁcation should be systematically used in patients
with CNS lesions, although based on a study with no statistical
analysis. Garland et al. noted a possible association between risk of
recurrence and radiographic grade (maturity and extent) of the
NHO in SCI patients [49]. The authors also found an association
between the risk of recurrence and number of NHOs ( 3) in
another study of TBI patients [42]. A few years later, a study by
Ebinger et al. found no association between risk of recurrence and
preoperative Brooker status [23].
3.2.3.2. Since 2002. Consensus is lacking for radiographic classiﬁ-
cation of NHO [18,37]. Several teams have tried to ﬁnd a link
between the risk of recurrence and the preoperative extent of the
NHO; however, results were based on clinical observations and
therefore were only descriptive [8,37,39]. The Brooker classiﬁca-
tion remains the most widely used, although its validity has never
been evaluated in patients with neurological disorders or in joints
other than the hip [27,36,37]. A disadvantage of the scale, as
highlighted by Mavrogenis et al., is that it does not indicate in
which anatomical compartment the HO is situated [37]. Conse-
quently, there is no correlation between the score and the extent of
the HO in each compartment, so boundaries cannot be determined.
Equally, the classiﬁcation does not help the surgeon determine the
surgical approach and the prognosis. Moreover, similar to
orthopedic-related HO [50], the Brooker scale gave pessimistic
expectations of hip range of motion. Indeed, hip HOs classiﬁed as
Brooker scale III or IV were not clinically ankylosed [37].
3.2.3.3. BANKHO database [10]. A case–control study using the
BANKHO database [36] found no signiﬁcant relationship between
recurrence and extent of NHO around the joint or Brooker status,
even when all matching factors were included in the analysis.
4. Discussion
This is the ﬁrst study, based on a large database of patients as
well as results from the literature, assessing whether the timing of
surgery, severity of the neurological sequelae and size of the NHO
after TBI are risk factors for NHO recurrence after surgical excision.
The literature search revealed that few good quality studies have
been performed on this subject and even fewer are speciﬁc to TBI.
However, the results from recent studies and those from the
BANKHO database suggest that the timing of surgery, the
functional and cognitive status of the patient and the volume of
the NHO do not appear to be risk factors for post-surgical
recurrence of NHO after TBI, as was proposed after SCI [51]. These
ﬁndings have important consequences for clinical practice.
Delaying surgery and allowing ankylosis to occur increases the
risk of bone loss beneath the NHO and increases the risk of fracture
during or after surgery. Early excision should allow patients to
reach their functional potential because they will not be impeded
by restrictions in movement. The surgery would also improve
comfort and reduce pain. Therefore, we recommend surgical
excision of NHO as soon as comorbid factors are under control and
the NHO is sufﬁciently constituted for excision (a surgical cleavage
plane with soft tissue).
However, to reduce the delay before excision, diagnostic
techniques must be improved. Diagnosis is particularly difﬁcult
in the early phase of NHO development because of the frequent
presence of motor, sensory and cognitive impairments, NHO
symptoms are non-speciﬁc, and signs do not appear on X-ray for
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no longer appears essential because surgical excision of NHO can
be carried out as soon as it is diagnosed (as long as the bone is
sufﬁciently mineralized, comorbid factors are under control and
the cleavage plan has been determined). For several decades,
serum alkaline phosphatase (SAP) was considered the best marker
for early diagnosis and used to determine the recurrence risk of
NHO [38]. However, since the early 1980s, Garland et al. reported
that the heterogeneous values of SAP found in several patients with
TBI generated controversies and confusion regarding the interpre-
tation of results and therefore the risk of recurrence (even if it is a
good early marker of NHO) [31]. The authors also reported that
normal bone scan ﬁndings and alkaline phosphatase levels and the
mature radiographic appearance of HO were not reliable predictors
of recurrence after SCI [49]. Physicians and physiotherapists
should regularly monitor the 4 main sites of NHO development
(hip, elbow, knee and shoulder) after severe TBI in order to
diagnose this complication as soon as possible. Management could
then be planned taking into account clinical ﬁndings (mainly
impact on function and pain) and radiological results (radiography
and CT scan for the development of the NHO, any nerve or vessel
compression, potential surgical approach) in decisions such as the
need for surgical excision.
4.1. Evaluation of recurrence
One problem relating to the evaluation of NHO recurrence is
that we lack an accepted deﬁnition of recurrence. Recurrence may
be seen on X-ray or may be a clinical ﬁnding without any impact on
patient function (e.g., a decrease in range of motion with no change
in function), or the patient may experience pain and/or loss of
function [37]. The rate of recurrence found in the BANKHO
database (5.6% [16/304]; 16 patients) was lower than that reported
in the literature (from 17% to 58% [8,42,53]) likely because only
patients who required surgical revision of an HO excision were
included. A large number of recurrences (radiographic and/or
clinical) were not considered as of clinical importance because
they did not affect patient function and were therefore not treated.
The evaluation of the incidence of recurrence should be homoge-
nized in prospective studies so that only recurrences requiring
intervention are taken into account.
4.2. Other factors that may inﬂuence risk of recurrence
Recurrence of NHO may be affected by factors other than the
3 beliefs addressed in this review. For example, we lack guidelines
on the effect of the timing of rehabilitation after NHO excision, and
practices differ. Rehabilitation was begun immediately post-
excision in most of the studies included in the review [8];
however, in our center, mobilization of the joint is delayed until
1 week after surgery to allow for treating postoperative
inﬂammation. This recommendation is associated with the
systematic addition of NSAIDs for at least 1 week after surgery
[10,38] because local inﬂammation seems to have a strong impact
on NHO formation [12]. Results in terms of range of motion did not
appear to be affected by this period of rest after the surgical
removal. However, prospective studies should be carried out to
determine the optimal time to begin rehabilitation post-excision.
4.3. Rehabilitation and NHO management
To our knowledge, no recent articles have addressed the subject
of early rehabilitation after central neurological damage (before
the appearance of NHO), rehabilitation in the presence of NHO, or
guidelines for rehabilitation after surgical removal of NHO possibly
because of the natural history of NHO development. Manyconfounding risk factors and symptoms of NHO do not appear
immediately, so diagnosis is delayed, for difﬁculties in assessing
management strategies. For several decades, NHO was believed
caused by strong mobilization techniques in physiotherapy.
However, not beginning regular mobilization early is now
considered a risk factor for NHO development. Immobilization
itself is an important risk factor. Moreover, the belief that surgery
should be delayed for several months to avoid recurrence likely
affected rehabilitation practice. New knowledge of NHO develop-
ment has led to a change in practice, with treatment speciﬁc to
each phase. During the early phase in the intensive care unit,
before the appearance of any NHO, treatment is based on
controlling inﬂammation and infection, and regular mobilization
(at least once per day). During NHO development, it is essential to
maintain range of motion, control pain and monitor any
neurovascular complications. The main goal of mobilization during
this phase is to maintain range of motion to avoid or delay joint
ankylosis so that rehabilitation and some function can be initiated.
If the NHO develops quickly, the aim is to achieve or maintain
sufﬁcient range of motion to enable changes in position (e.g.,
sitting for hip NHO) while waiting for surgery to remove the NHO.
Following surgery, since local inﬂammation seems to be an
important risk factor in the development of NHO, patients should
be given NSAIDs and gentle mobilization should not begin until
1 week after surgery, to reduce the risk of recurrence.
4.4. Limitations
The main limitation in our study is the lack of quality
prospective studies on NHOs (and its recurrence) to compare to
data from the BANKHO database. Indeed, because the diagnosis is
retrospective, the pathogenesis is still misunderstood and
concerns at worst 23% of severe TBI, so performing studies with
a good level of evidence is impossible. The development of an
animal model of NHO after spinal cord lesion can help in better
understanding the mechanisms involved [54]. Moreover, a
retrospective and prospective analysis could be a limitation of
the studies based on the BANKHO database; however, prospective
studies of NHO management are difﬁcult to perform, mainly
because of difﬁculties in early diagnosis. All data from the BANKHO
database from a single centre with one surgeon performing all the
interventions may have led to some bias. However, this study is
among the ﬁrst to assess the impact of the timing of surgery on
recurrence of NHO in patients with TBI with an epidemiological
approach.
4.5. Perspectives
Further studies are required to increase our understanding of
the pathophysiological mechanisms leading to NHO. The develop-
ment of an animal model of acquired HO after CNS lesion would
allow for independently investigating all retrospective factors
found by clinicians and evaluating their impact on the early
process of development of HO. Guidelines are needed on the
diagnosis and management, and clear deﬁnitions of NHO and
recurrence are needed. Prophylaxis for NHO also needs to be more
extensively investigated to develop appropriate methods. Until we
have a greater understanding of this condition, the only curative
treatment will remain surgery. We need a consensual approach for
patients who need to recover movement capacity and autonomy as
soon as possible [17,55–57].
5. Conclusions
Despite the poor quality of studies, our results from the
literature and with those from studies based on the BANKHO
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excision, the severity of the neurological sequelae or the
preoperative extent of the NHO may not be associated with risk
of NHO recurrence. Therefore, we recommend surgical excision of
NHO as soon as comorbid factors are under control and the NHO is
sufﬁciently constituted for excision.
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